Medpace Holdings, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Medpace Holdings, Inc. (MEDP) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $506.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-10
- Medpace Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $506.90M, a 11.54% increase from fiscal 2024.
- Medpace Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $454.45M, a 45.25% increase from fiscal 2023.
- Medpace Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $312.87M, a 20.07% increase from fiscal 2022.
- Medpace Holdings, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $260.56M, a 38.94% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|
| 2025-12-31 | $506.90M 10-K · filed 2026-02-10 | |
| 2024-12-31 | $454.45M 10-K · filed 2026-02-10 | |
| 2023-12-31 | $312.87M 10-K · filed 2026-02-10 | |
| 2022-12-31 | $260.56M 10-K · filed 2025-02-11 | |
| 2021-12-31 | $187.53M 10-K · filed 2024-02-13 | |
| 2020-12-31 | $158.43M 10-K · filed 2023-02-14 | |
| 2019-12-31 | $117.33M 10-K · filed 2022-02-15 | |
| 2018-12-31 | $88.01M 10-K · filed 2021-02-16 | |
| 2017-12-31 | $52.99M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $18.02M 10-K · filed 2019-02-26 | |
| 2015-12-31 | -$12.29M 10-K · filed 2018-02-27 | |
| 2014-12-31 | -$23.89M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |